ONYX-015 is an E1B-55K-deleted adenovirus that has promising clinical activity as a cancer therapy. However, many tumor cells fail to support ONYX-015 oncolytic replication. E1B-55K functions include p53 degradation, RNA export, and host protein shutoff. Here, we show that resistant tumor cell lines fail to provide the RNA export functions of E1B-55K necessary for ONYX-015 replication; viral 100K mRNA export is necessary for host protein shutoff. However, heat shock rescues late viral RNA export and renders refractory tumor cells permissive to ONYX-015. These data indicate that heat shock and late adenoviral RNAs may converge upon a common mechanism for their export. Moreover, these data suggest that the concomitant induction of a heat shock response could significantly improve ONYX-015 cancer therapy.
Introduction
ONYX-015 has undergone extensive clinical testing with proven safety and evidence of promising clinical activity from Oncolytic viruses that undergo selective lytic replication in tuseveral indications (Khuri et al., 2000; Kirn, 2001 ; Reid et al., mor cells have the potential to fulfill many of the aspirations 2002; Ries and Korn, 2002; Rudin et al., 2003) . Initially, ONYXof cancer therapy (Chiocca, 2002; Dobbelstein, 2004; 015 was evaluated by direct intratumoral injections in head and 2005). dl1520/ONYX-015 is the prototype for oncolytic adenoneck patients who had failed prior chemotherapy. When viral therapy (Bischoff et al., 1996) and the first such genetic ONYX-015 was combined with conventional chemotherapy, agent to be tested in humans (Khuri et al., 2000) . over 63% of injected tumors showed significant regression lacks the E1B-55K gene product for p53 degradation and (Khuri et al., 2000) . In contrast, normal cells, injected adjacent therefore was predicted to selectively replicate in tumor cells to the tumor mass, showed no adverse effects to ONYX-015 in which the p53 pathway is inactive (Barker and Berk, 1987;  therapy. Clinical responses have also been observed in recent Bischoff et al., 1996) . In contrast, in primary cells, the loss of studies, in which ONYX-015 was injected into unresectable E1B-55K-mediated p53 degradation was expected to activate pancreatic carcinomas (Hecht et al., 2003) and peritumoral rea p53 checkpoint that would limit ONYX-015 replication. Congions of recurrent malignant gliomas (Chiocca et al., 2004) . In sistent with this, ONYX-015 replication is attenuated in primary patients suffering from metastatic colorectal cancer, the intracells but replicates to wild-type virus levels in many tumor cell vascular delivery of ONYX-015 to the liver provoked tumor relines. In addition to its role in p53 inactivation, E1B-55K has gressions, with evidence of prolonged viremia and fever in relate functions that include the shutdown of host protein synthesponsive patients (Reid et al., 2002) . In addition, promising sis and the preferential export and translation of late viral clinical efficacy was observed when ONYX-015 was adminismRNAs, both necessary events for a productive viral infection tered as a mouthwash to patients suffering from premalignant (Babiss et al., 1985; Leppard and Shenk, 1989; Pilder et al., oral leukoplakia (Rudin et al., 2003) . Moreover, ONYX-015 has 1986). Recently, it was shown that the loss of E1B-55K-medirecently been "armed" with genes encoding prodrug converting enzymes (Stubdal et al., 2003) or endostatin (Li et al., 2005) , ated late functions, rather than p53 inactivation, is the major determinant of ONYX-015's oncolytic selectivity (O 'Shea et which would be expected to further enhance ONYX-015's clinical activity. Taken together, ONYX-015 has a promising clinical al., 2004).
profile for the treatment of disparate tumor types. Nevertheless, as efficiently as wild-type virus (WtD), ( Figure 1A ). In contrast, the shutoff of host protein synthesis was impaired in ONYXto date ONYX-015 has not completed randomized clinical trials, 015-infected resistant tumor cell lines, such as U2OS and so its objective therapeutic value is hard to assess. While many Ovcar-3. patients exhibited sustained clinical responses to ONYX-015 ONYX-015-infected permissive tumor cells export late viral treatment, this varied considerably, and some patients experiRNAs, such as fiber and hexon, five to ten times more effienced no clinical relief of their disease. Therefore, understandciently than ONYX-015-infected primary cells (O'Shea et al., ing the molecular basis of ONYX-015 tumor cell resistance, or 2004) . Therefore, we used an RNA fluorescent in situ hybridizaalternatively, how to sensitize refractory tumor cells to ONYXtion assay (FISH) to visualize the localization of the late viral 015 treatment, has important therapeutic implications.
100K mRNA in resistant and permissive tumor cell lines. In In tissue culture, tumor cell lines also vary considerably in ONYX-015-infected U2OS cells, 100K mRNA export is delayed their ability to support ONYX-015 replication (see Table S1 in compared to WtD-infected cells ( Figure 1B ). In contrast, in the Supplemental Data available with this article online). For HCT-116 cells, 100K mRNA is exported in ONYX-015 infection example, ONYX-015 replicates to wild-type virus levels in HCT- analogous to that of WtD ( Figure 1C ). These data suggest that 116 colorectal cancer cells (permissive), whereas it is attenudifferences in providing the late functions of E1B-55K underlie ated by almost 100-fold in U2OS osteosarcoma cells (resisthe variable ability of tumor cell lines to support ONYX-015 reptant). The aim of this study was to understand the mechanism lication. underlying tumor cell resistance to ONYX-015, with the ultimate goal of either predicting responsive tumor types and/or 100K expression is rate limiting for ONYX-015 sensitizing refractory cancer cells to ONYX-015 therapy. Here, tumor cell replication we show that, in contrast to permissive tumor cell lines, refracSeveral previous studies have shown that the presence of cytory tumor cells infected with ONYX-015 fail to shut down celtoplasmic fiber and hexon RNAs correlates with tumor cell perlular protein synthesis in the absence of E1B-55K. We show missivity to ONYX-015 (Goodrum and Ornelles, 1998 ; Goothat the shutdown of cellular protein synthesis in permissive drum and Ornelles, 1999; Harada and Berk, 1999) . However, tumor cells is a secondary consequence of 100K mRNA exthis does not appear to explain how host protein shutoff might port, an event normally regulated by E1B-55K, and rate limiting also be achieved in the absence of E1B-55K. In Figure 1 , we for ONYX-015 replication. The 100K protein acts downstream demonstrate that ONYX-015-infected resistant tumor cells fail of E1B-55K to inhibit the translation of capped cellular mRNAs, to mediate host protein shutoff and inefficiently export 100K while viral RNAs are preferentially translated due to their pos-RNA compared to permissive cell lines. In adenovirus infection, session of a unique 5#UTR (Cuesta et al., 2000b; Hayes et al., 100K inhibits the translation of many cellular mRNAs but pro-1990) . Moreover, we demonstrate that the induction of a cellumotes the translation of late viral RNAs (Cuesta et al., 2000b ; lar heat shock response, through physical or pharmacological Hayes et al., 1990) . Consequently, 100K mutant viruses are demeans, selectively rescues the export of late viral RNAs, such fective for host protein shutoff and replication (Hayes et al., as 100K, hexon, and fiber, in resistant tumor cells, rendering 1990; Morin and Boulanger, 1986) . Therefore, we hypothesized them competent for ONYX-015 replication. These data suggest that the differences in host protein shutoff in ONYX-015-that in adenoviral infection and a cellular heat shock response, infected resistant versus permissive tumor cell lines may, in part, RNA export may be similarly regulated. In addition, this study be explained by disparities in their expression levels of 100K. suggests that the induction of a heat shock response, by feConsistent with this hypothesis (and Figures 1B and 1C) , brile temperatures or pharmacological adjuvants, would greatly 100K expression is defective in ONYX-015-infected U2OS cells enhance the clinical efficacy of ONYX-015 as a cancer therapy.
but expressed at WtD levels in ONYX-015-infected HCT-116 cells ( Figure 2A ). We next investigated whether stable ectopic Results expression of 100K would render U2OS cells permissive for ONYX-015 replication. Ectopic 100K expression resulted in the Tumor cell differences in providing the host protein enhanced expression of late viral proteins (such as hexon, penshutoff and RNA export functions of E1B-55K correlate ton, and fiber) in ONYX-015-infected U2OS cells ( Figure 2B ), with ONYX-015 permissivity/resistance consistent with 100K's role in promoting the translation of late Previously, we demonstrated that the propensity of permissive viral RNAs. Moreover, siRNA-mediated knockdown of 100K retumor cells to support ONYX-015 replication correlated with duced late viral protein expression in ONYX-015-infected HCTtheir unexpected ability to shut down host protein synthesis 116 cells ( Figure 2C ). In ONYX-015-infected U2OS cells, ecand export late viral RNAs in the absence of E1B-55K, a protopic 100K also resulted in enhanced cytopathic effect (CPE) pensity not shared by primary cells (O 'Shea et al., 2004) . and a 10-fold increase in viral yield ( Figures 2D and 2E) . NeverTherefore, we hypothesized that the variable replication of theless, ONYX-015 replication was not restored to WtD levels, ONYX-015 in tumor cell lines (Table S1) In many ways, the cellular response to heat shock resembles We conclude that the export and translation of late viral RNAs, the late stages of adenovirus infection. During a heat shock such as 100K (this study), together with hexon and fiber (Gooresponse, the translation of cellular mRNAs is inhibited, to predrum and Ornelles, 1998; Goodrum and Ornelles, 1999; Har- vent the further accumulation of misfolded proteins. However, ada and Berk, 1999) , in the absence of E1B-55K, determine a heat shock mRNAs are preferentially translated via a ribosome tumor cell's ability to support ONYX-015 replication. Unfortushunting mechanism, whereupon they promote cell survival nately, the mechanics and regulation of mammalian and adethrough their functions as molecular chaperones (Rhoads and noviral RNA export are poorly understood. In contrast, more is Lamphear, 1995) . The 5#UTR of mammalian Hsp70 and late known about the control of mRNA translation, including that of adenoviral mRNAs share significant structural homology, which late adenoviral RNAs. In Figure 2E , we show that ectopic 100K
facilitates their selective translation through a common mechaexpression, which promotes late viral mRNA translation (Cuesta nism in a cellular heat shock response or viral infection (Yueh et al., 2000b) , rescues ONYX-015 replication by up to 10-fold and Schneider, 2000) . dl1520/ONYX-015 has previously been in the resistant U2OS tumor cell line. Therefore, we reasoned described as a "cold-sensitive" virus and replicates poorly at low temperatures (Harada and Berk, 1999; Ho et al., 1982 ; that selectively invoking 100K-like functions in resistant tumor Control and myc-100K-expressing U2OS cells were infected with either ONYX-015 or WtD. Protein lysates were examined by Western blotting for the expression of Ad5 proteins (hexon, penton, and fiber), p53, and myc-100K. C: HCT-116 cells were transfected with either 100K siRNA or nonsilencing control siRNA and infected with ONYX-015. Protein lysates were examined for 100K and Ad5 late protein expression. D and E: Stable U2OS cell clones for either myc-100K or control vector were infected with either ⌬E1A, ONYX-015, or WtD. D: Cytopathic effect (CPE) was visualized at 72 hpi. E: ONYX-015 and WtD viral yield at 48 hpi was measured by quantifying total plaque-forming units (pfu) in 293E4s. Leppard and Shenk, 1989) . Therefore, we wondered if the expected to detect it. Nevertheless, given the functions of 33K, we are currently investigating the identity of this cryptic 33 kDa "cold sensitivity" might instead be a "heat dependency," and if heat shock would enhance late viral protein expression in protein band. Since 39.4°C is within the range of temperatures experi-ONYX-015-infected U2OS cells.
We examined late protein expression in ONYX-015-infected enced by patients exposed to high doses of ONYX-015 (Reid et al., 2001), we chose to study the effect of this temperature U2OS cells at various temperatures. Temperatures of 39.4°C-40°C for 4-18 hr postinfection (hpi) were sufficient to enhance on ONYX-015 replication further. Incubation at 39.4°C results in a bona fide cellular heat shock response as evidenced by the expression of late viral proteins in ONYX-015-infected U2OS cells, although prolonged incubation at 44°C was too the induction of heat shock mRNAs such as Hsp70, Crystallin αB, Hsp27, and Hsp90 ( Figure 3B ). In Figure 3C , we show that severe and inhibited late viral protein synthesis even in WtDinfected cells ( Figure S1 and data not shown). Incubation at incubation at 39.4°C also rescued 100K expression in ONYX-015-infected U2OS cells and, consistent with this, host protein 39.4°C significantly rescues the expression of the majority of late viral proteins in ONYX-015-infected U2OS cells, including shutoff ( Figure 3D ). hexon, penton, fiber, V, VI, and VII ( Figure 3A ). We also observed a protein of approximately 33 kDa that is absent in Heat shock rescues the export of late viral RNAs ONYX-015-infected lysates compared to WtD, and which is not in ONYX-015-infected U2OS cells We next investigated the mechanism whereby heat shock resrescued by heat shock. The molecular weight of this protein would be consistent with that of the late viral L4-33K protein, cues late viral protein synthesis and host protein shutoff in ONYX-015-infected U2OS cells. The inhibition of cap-depenwhich functions in virion assembly and the early to late switch in viral protein expression (Farley et al., 2004; Fessler and dent translation in mammalian cells exposed to chronic heat shock (44°C) is thought to be mediated through a reduction in Young, 1999) . However, 33K is not present in the mature virion, and antisera raised against mature viral particles would not be soluble eIF-4G, and consequently phospho-eIF-4E, bound to (Cuesta et al., 2000a) . However, in Figure 4A , we sufficient to rescue the export of 100K mRNA (and by inference host protein shutoff) in ONYX-015-infected U2OS cells. Heat show that incubation of U2OS cells at 39.4°C does not reduce either the total levels of phospho-eIF-4E or the fraction of eIFshock also rescued, albeit to a lesser extent, the export of other late viral RNAs, such as fiber and hexon ( Figure 4D and 4E capable of binding to the cap analog methyl 7 GTP sepharose. Indeed, this is consistent with the original report of heat Supplemental Data, respectively). From this we conclude that incubation of ONYX-015-infected U20S cells at 39.4°C phenoshock effects on translation, which demonstrated that the eIF-4G-heat/stress granules do not form at lower temperatures copies the functions of E1B-55K in the export of the late viral RNAs, 100K, hexon, and fiber, together with host protein (Cuesta et al., 2000a) , such as, in our case, 39.4°C. Therefore, effects on eIF-4E at 39.4°C do not appear to account for the shutoff. shutdown in cellular protein synthesis observed in ONYX-015-infected U2OS cells in Figure 3D .
Heat shock rescues ONYX-015 replication We next investigated whether heat shock increased the tranin nonpermissive tumor cells scription of late viral mRNAs such as 100K and fiber in ONYXWe next determined whether heat shock-induced late viral 015-infected U2OS cells. However, the ratio of 100K or fiber RNA export was sufficient to rescue ONYX-015 replication in mRNA levels in ONYX-015-versus WtD-infected U2OS cells resistant tumor cells. Incubation of U2OS cells at 39.4°C redid not increase at 39.4°C compared to 37°C ( Figure 4B ). In sulted in CPE ( Figure 5A ) and a 30-fold increase in ONYX-015 yeast, heat shock has been shown to induce the preferential viral yield ( Figure 5B ). In contrast, WtD yield increased by at nuclear export of Hsp mRNAs, while global RNA export is conmost 2-fold at the elevated temperature, as has been noted comitantly inhibited (Saavedra et al., 1996; Saavedra et al., before (Haviv et al., 2001 ). 1997). Therefore, we examined whether the incubation of
We next investigated whether a heat shock response could ONYX-015-infected U2OS cells at 39.4°C rescues the export rescue ONYX-015 replication in a panel of resistant tumor cell of late viral RNAs, which, as we have demonstrated, appears lines. Incubation of ONYX-015-infected MDA-MB-231, MDA-MB-453, SK-BR-3, HCC38, HCC3153, and MDA-MB-415 tuto be the major limitation to ONYX-015 replication in these cells. Figure 4C demonstrates that incubation at 39.4°C was mor cell lines at 39.4°C rescued the expression of late viral proteins, as shown in Figure 5C . Moreover, incubation at function, thereby provoking a secondary misfolded protein/ heat shock response, which includes the induction of Hsp70. 39.4°C also resulted in, on average, an 8-fold increase in ONYX-015 replication (Table 1 ). In contrast, the incubation of Herbimycin A resulted in a strong induction of Hsp70 in ⌬E1A (a nonreplicating virus control for infection)-infected U2OS ONYX-015-infected permissive tumor cell lines, such as C33A, at 39.4°C resulted in at most a 2-fold increase in replication cells, consistent with a bona fide heat shock response ( Figure  6A ). Herbimycin A, like elevated temperature, also rescued ( Figure S3 ) and had minimal effects on late protein expression, ostensibly because E1B-55K late functions are already com-100K protein expression ( Figure 6B ) and host protein shutoff in ONYX-015-infected U2OS cells ( Figure 6C ). In addition, herbiplemented.
mycin A increased ONYX-015 viral yield, without overtly affecting that of WtD, in infected U2OS cells ( Figure 6D ). We also Benzoquinoid ansamycins rescue ONYX-015 production conducted a dose-response experiment with herbimycin A/gelin resistant tumor cells danamycin to determine if there was an optimal concentration The effects of elevated temperatures on ONYX-015 replication that would maximally rescue ONYX-015 replication in U2OS could be due to the destabilization of temperature-sensitive cells ( Figure 6E ). We found that a concentration of 200-400 ng/ proteins and/or the induction of a cellular heat shock response.
ml geldanamycin increased ONYX-015 viral yield up to 130-Therefore, we investigated whether pharmacological inducers fold, close to a complete rescue to WtD levels. of a heat shock response could also rescue ONYX-015 replicaSimilar to incubation at 39.4°C, treatment with benzoquinoid tion in resistant tumor cells. One such class of compounds is ansamycins enhances the yield of ONYX-015 in a panel of rethe benzoquinoid ansamycins, which include herbimycin A (Hegde et al., 1995) , radicicol, geldanamycin, and 17-AAG sistant tumor cell lines (Table 1) . Geldanamycin or 17-AAG resulted in a 10-fold, or greater, increase in ONYX-015 replication (Neckers, 2002) . These compounds block Hsp90 chaperone in eight out of ten resistant tumor cell lines tested. Taken tocent primary cells, to try to reflect the physiological state of the majority of normal epithelial cells within the body. In contrast gether, these data demonstrate that drugs that elicit a heat shock response can significantly rescue ONYX-015 replication to resistant tumor cells, heat shock did not rescue 100K expression in ONYX-015-infected primary SAECs ( Figure 7A ). Inin many refractory tumor cell lines.
deed, in infected SAECs, ONYX-015 replication was further attenuated by incubation at 39.4°C, or by treatment with Induction of a cellular heat shock response fails to rescue ONYX-015 replication in primary human cells herbimycin A, as shown in Figure 7B . Surprisingly, WtD replication was also attenuated by up to 50-fold under these condiTo have a potential clinical application, the induction of a cellular heat shock would have to maintain, or indeed improve, the tions. Moreover, these conclusions hold true for a panel of primary cells. Incubation at 39.4°C or treatment with herbimycin therapeutic index of ONYX-015 for tumor versus normal cells. Previously, we found that ONYX-053, a novel adenovirus mu-A/geldanamycin, for the most part, decreased ONYX-015 replication in primary keratinocytes, astrocytes, mammary epithelial tant that is defective for E1B-55K-mediated p53 degradation but retains E1B-55K late functions (Shen et al., 2001) , replicells, and bronchial epithelial cells ( Figure 7C and Table S2 ). Treatment with 17-AAG resulted in up to 2.1-fold increases in cated to almost wild-type virus levels in primary cells (O 'Shea et al., 2004) . Thus, our attempts at genetically engineering an ONYX-015 viral yield in primary cells, but in comparison to tumor cells, these effects are minimal. In addition, heat shock E1B-55K mutant virus with enhanced replication in resistant tumor cell lines also ablated oncolytic selectivity. Therefore, we appears to decrease both WtD and ONYX-015 viral yield irrespective of whether normal cells were proliferating or rendered would have expected the induction of a cellular heat shock response to have a similar effect, and to rescue ONYX-015 repquiescent prior to infection. We examined whether a heat shock response resulted in prelication in primary cells, obviating any potential clinical utility of a heat shock/ONYX-015 combination cancer therapy. mature apoptosis, cell cycle arrest, or defective p53 degradation in adenovirus-infected primary cells. Heat shock had no Notwithstanding, we examined the effect of elevated temperature and herbimycin A on ONYX-015 replication in primary appreciable effect on apoptosis or cell cycle entry, as evidenced by PARP/caspase 3 cleavage or cyclin A induction (an quiescent small airway epithelial cells (SAECs). We used quies- Resistant tumor cell lines were infected with ONYX-015 and incubated at either late viral proteins. In addition, 100K also plays an important 37°C or 39.4°C, or in the presence of benzoquinoid ansamycins. Radicicol was used at 5 M; 17-AAG was used at 100 ng/ml; herbimycin A was used at 500 role in hexon trimerization and viral assembly (Cepko and ng/ml, except for LNCaP, which received 2500 ng/ml; and geldanamycin was Sharp, 1982; Morin and Boulanger, 1986) . We show that 100K used at 100 ng/ml, except for U2OS, Ovcar-3, and LNCaP, which received 400 expression is limiting in ONYX-015-infected resistant tumor ng/ml, and MDA-MB-231 and -453, which received 500 ng/ml. Viral yield was cells, and necessary in ONYX-015-infected permissive tumor late viral RNA export of capsid RNAs such as fiber and hexon, and 100K RNA for host protein shutoff and viral morphogenesis. Similarly, the ability of permissive tumor cells to support ONYX-015 replication also resolves to a single property: the export of late viral RNAs in the absence of E1B-55K. E2F target), respectively ( Figure 7D ). WtD degraded p53 at Our next objective was to try to extend ONYX-015 replicaboth 37°C and 39.4°C, implying that the effects of heat shock tion to refractory tumor cells. However, the molecular mechain decreasing wild-type viral replication were not related to efnisms underlying both adenoviral and mammalian RNA export fects on p53. This suggests that the disparity between normal are poorly understood, and not obviously tractable to manipuand tumor cells with respect to the effect of heat shock on lation. Therefore, given that ectopic expression of 100K in virus production may be unrelated to the disruption of the RB/ U2OS cells increased ONYX-015 replication by up to 10-fold, p53 checkpoints and reflect a novel difference. Taken together, we initially chose to focus on strategies that might be used these data indicate that the combined use of ONYX-015 with therapeutically to mimic 100K-mediated translation of late viral agents that elicit a heat shock response could significantly imRNAs. However, neither rapamycin treatment, which inhibits mTOR, nor SB203580 together with U0126 treatment, which prove and broaden ONYX-015's therapeutic utility. A: U2OS cells were mock infected with ⌬E1A virus and treated with herbimycin A (500 ng/ml). Hsp70 expression was analyzed by Western blotting. B: U2OS cells were infected with either ⌬E1A, ONYX-015, or WtD and treated with herbimycin A (500 ng/ml). Protein lysates were analyzed for 100K expression by Western blotting. C: Host protein shutoff was examined at 48 hpi in U2OS cells infected with either ⌬E1A, ONYX-015, or WtD and incubated in the presence/absence of herbimycin A (500 ng/ml). D: ONYX-015 or WtD viral yield was measured in U2OS cells incubated in the presence/absence of herbimycin A (500 ng/ml). E: A dose-response curve with herbimycin A or geldanamycin was performed in ONYX-015-infected U2OS cells. Viral yield was measured at 48 hpi.
Discussion
inhibits mnk-1 phosphorylation of eIF-4E (Wang et al., 1998), sent or not. Indeed, a severe defect in late viral protein synthesis was observed at 32°C in the H1299 tumor cell line (Harada nor expression of the poliovirus 2a pro , which cleaves eIF-4G (Castrillo and Carrasco, 1987) , rescued 100K functions and late and Berk, 1999). However, there was only a modest, at most 2-fold, decrease in cytoplasmic fiber and hexon mRNA, and so viral protein production in ONYX-015-infected U2OS cells (data not shown). Indeed, this is perhaps not surprising in light of effects of temperature on viral protein translation were conjectured as the likely cause. These studies, together with the recent elegant studies, which revealed that 100K possesses a selective binding element for the tripartite leader of late viral knowledge that heat shock and late viral RNAs have structurally similar 5#UTRs (Yueh and Schneider, 2000) , prompted us RNAs, and simultaneously binds to eIF-4G (consequently displacing mnk), to drive 40S ribosome recruitment and the transto determine if heat shock could rescue ONYX-015 replication in resistant tumor cells. Incubation of refractory tumor cells at lation of viral RNAs (Cuesta et al., 2004) . Nevertheless, our inhibitor experiments imply that any nominal strategy that 39.4°C rescued late viral protein expression and host protein shutoff. The relatively mild heat shock temperature of 39.4°C decreases the translation of cellular mRNAs does not necessarily mimic the specific effects of a heat shock response on did not affect phospho-eIF-4E binding to methyl 7 GTP in ONYX-015-infected U2OS cells. Instead, heat shock induces ONYX-015 replication.
E1B-defective adenoviruses have been described as "coldresistant tumor cells to export late viral RNAs, the primary impediment to ONYX-015 replication in these cells. Thus, heat sensitive viruses" (Ho et al., 1982) . Recent studies, which made use of temperature-sensitive p53 mutants (stable at 32°C and shock-mediated host protein shutoff in ONYX-015-infected nonpermissive tumor cells is most likely a secondary result of unstable at 39°C) to examine the role of p53 on ONYX-015 replication, also reported a confounding effect of temperature 100K RNA export and expression. We find that late viral messages depend on E1B-55K for their on ONYX-015 replication, irrespective of whether p53 was pre- Figure 7 . Induction of a cellular heat shock response fails to rescue ONYX-015 replication in primary human cells A: Primary quiescent small airway epithelial cells (SAECs) were infected with either ⌬E1A, ONYX-015, or WtD and incubated at either 37°C or 39.4°C. 100K expression was examined by Western blotting. B: Viral production was measured in SAECs that had been infected with either ONYX-015 or WtD and incubated at either 37°C or 39.4°C, or in the presence of 500 ng/ml herbimycin A. C: The ratio/fold change of ONYX-015 viral yield at 72 hpi in infected quiescent (Q) or proliferating (P) primary cells incubated at either 39.4°C, or in the presence of either herbimycin A (SAECs), geldanamycin (500 ng/ml), or 17-AAG (100 ng/ml), is shown relative to cells incubated at 37°C. Actual titers obtained in these experiments are included in Table S2 . Herb A, herbimycin A; Geld A, geldanamycin; HMECs, human mammary epithelial cells; BLD, below limit of detection; ND, not done. D: SAECs were infected with either ⌬E1A, ONYX-015, or WtD and incubated at either 37°C or 39.4°C. Protein lysates were harvested and examined by Western blotting with the indicated antibodies.
export to different degrees, with hexon > fiber > 100K, and that kinetics of late protein expression observed in ONYX-015-infected cells. Nevertheless, the ability of heat shock to rescue this is also reflected in the extent to which a heat shock response rescues their export ( Figures 4C and 4D and Figure late viral RNA export and consequently ONYX-015 replication indicates that it is a critical rate-limiting factor in resistant tu-S2). This may reflect the temporal expression of these messages (Farley et al., 2004) , their distance from the late viral promor cells.
We also demonstrate that pharmacological inducers of a moter (Flint and Gonzalez, 2003) , or molecular motifs within these RNAs that influence their mode of export. In addition, heat shock response, such as the benzoquinoid ansamycins, rescue late protein expression, host shutoff, and viral replicathe extent to which late viral proteins depend on E1B-55K for their expression is not absolute but instead particularly extion in ONYX-015-infected resistant tumor cells. These agents inhibit Hsp90, which triggers a misfolded protein response and acerbated early in infection. One explanation for this is that late viral RNA transcripts accumulate over time and so can more induction of Hsp70, akin to elevated temperature (Hegde et al., 1995) . Therefore, the effects of heat shock on late viral RNA effectively compete with cellular RNAs for nuclear export and/ or translation, despite the absence of E1B-55K/100K. In addiexport are unlikely to be mediated through Hsp90, given that herbimycin A inhibits this family of Hsps. Recently, the induction, 100K and L4-33K have been proposed to contribute to a "feed-forward" activation mechanism in mediating the early/ tion of Hsp70 and Hsp40 by the avian adenovirus protein GAM-1 was shown to be essential for virus replication, and late switch (Farley et al., 2004) , that may also account for the GAM-1 mutants were partially rescued by heat shock (Glotzer zymes that are thought to affect the efficacy of geldanamycin/ 17-AAG. Also, while we performed dose-response experiments et al., 2000). However, Hsp70 is unlikely to mediate the effects of heat shock in ONYX-015 replication, as it is potently induced in U2OS cells to determine an optimal concentration of geldanamycin that rescued ONYX-015 replication by up to 130-fold by E1A (the GAM-1 functional equivalent) in both wild-type (Nevins, 1982; Wu et al., 1986 ) and ONYX-015-infected cells (almost to the level of wild-type virus) ( Figure 6E ), due to practical considerations, this was not possible for all tumor cell lines (data not shown). Incubation of resistant tumor cells at 39.4°C for 10 hr early in infection is sufficient to rescue the effects tested. The ability of heat shock-induced late viral RNA export to fully rescue ONYX-015 to wild-type virus levels may also be of E1B-55K in late viral replication. This is consistent with the induction of an ordered sequelae of events during a heat shock compromised by "off-target" effects that negatively impact viral replication. Nevertheless, our data indicate that the induction response, such as activation of the heat shock transcription factor HSF-1 by both temperature (Cotto and Morimoto, 1999) of a cellular heat shock could extend ONYX-015 oncolytic therapy to many formerly refractory tumor cells. and geldanamycin (Zou et al., 1998) . However, overexpression of a constitutively active HSF-1 (Hegde et al., 1995) 
fails to
The effects of heat shock in enhancing ONYX-015 replication are restricted to tumor cells and, surprisingly, impair both wildrescue late viral protein expression in ONYX-015-infected U2OS cells (data not shown). The preferential export of heat type and ONYX-015 viral replication in primary SAECs. This may reflect a differential heat shock response in tumor versus shock RNAs has previously been observed upon heat shock of yeast, but the molecular mechanism is controversial, and the normal cells. Indeed, tumor-specific differences in Hsp regulation (Kamal et al., 2003) have been proposed to underlie the mammalian factors remain to be elucidated (Jensen et al., 2001; Saavedra et al., 1996; Santoro, 2000; Vainberg et al., cancer selectivity of drugs, such as geldanamycin/17-AAG, which are currently undergoing clinical evaluation. Notwith-2000) . Therefore, a novel component of the heat shock pathway appears to mediate these effects, which we are currently standing, our data indicate that heat shock appreciably eninvestigating.
hances the therapeutic index of ONYX-015 for tumor versus Our data suggest that heat shock and late viral RNAs may normal cells. This is in sharp contrast to results obtained with impinge on a common molecular mechanism for their nuclear ONYX-053 (Shen et al., 2001 ), a mutant virus that retains E1B-export. Consistent with this, Hsp70 mRNA continues to be ex-55K late functions to replicate more efficiently in resistant tuported to the cytoplasm late in viral replication, when the transmor cells but also replicates to almost wild-type virus levels in port of most cellular RNAs is inhibited (Moore et al., 1987) . primary cells (O 'Shea et al., 2004) . Moreover, patients treated From these data, we infer that late viral and Hsp RNAs may with high doses of ONYX-015 in clinical trials have experienced share a molecular resemblance that dictates their mode of exelevated body temperatures, presumably through inflammatory port. The 5#UTR of late adenoviral RNAs has structural homoleffects of virus infusion (Reid et al., 2001) . Indeed, these effects ogy to the 5#UTR of Hsp70 and 18S rRNA (Yueh and Schnei- have recently been proposed as a factor that may have signifider, 2000), which underlies their common property to be cantly affected the clinical outcome of ONYX-015 therapy translated by ribosome shunting. In addition to its role in trans- (Thorne et al., 2005) . Our data suggest that a clinical strategy lation, the 5#UTR of late viral mRNAs has also been shown to that does not advocate the use of pharmacological agents to play a role in export (Huang and Flint, 1998) . Taken together, suppress fever would favor the tumor-selective replication of these data suggest that heat shock and late viral RNAs may ONYX-015. Finally, this study indicates that induction of a heat share a common strategy for both translation and nuclear exshock response by pharmacological agents (that could potenport that is specified by their 5#UTRs.
tially be administered systemically) or local hyperthermia, could The upregulation of Hsps in tumor cells is well documented greatly augment and broaden ONYX-015's clinical utility as a (Jolly and Morimoto, 2000) . Therefore, it is intriguing to specucancer therapy. late that permissive tumor cells may constitutively deregulate Experimental procedures cellular players in the RNA export pathway that play a role in heat shock/stress responses. Interestingly, the localization of Cell culture YB-1, which plays a role in the transcription of multidrug resisPrimary cells were obtained from BioWhittaker, cultured as per the manutance genes, is affected by both E1B-55K and heat shock facturer's recommendations, and rendered quiescent through contact inhi- (Holm et al., 2002; Holm et al., 2004; Raffetseder et al., 2003) bition followed by prolonged (14-18 days) incubation in complete medium. and has recently been shown to have RNA binding functions Tumor cells were cultured in DMEM, except HCT-116 (McCoy's) and that regulate mRNA translation (Bader et al., 2003) . HCC3153, HCC38, Ovcar-3 and LNCaP, (RPMI-1640) , all of which were supplemented with 10% fetal calf serum. U2OS 100K and control stable cell These data have important and immediate clinical implicaclones were established by transfection with pcDNA3-myc-100K or control tions for ONYX-015 cancer therapy. Incubation at 39.4°C, or vector, respectively, followed by selection in 500 g/ml G418. Benzoquinoid treatment with geldanamycin/17-AAG, enhances the replicaansamycins were obtained from Sigma.
tion of ONYX-015 in a panel of resistant tumor cell lines. Indeed, geldanamycin/17-AAG resulted in a 10-fold, or greater,
Viral infections and quantification
increase in ONYX-015 viral yield in eight out of ten resistant Viruses included ⌬E1A, an E1A-deleted adenovirus (dl312), wild-type virus, WtD, and E1B-55K-deleted dl1520/ONYX-015 (Barker and Berk, 1987) . Vitumor cell lines tested. Nevertheless, inevitably, as with any ral infections and viral replication/yield assays were carried out as described therapy, in some tumor cell lines, such as HCC38 and previously (Johnson et al., 2002; , at multiplicity of infec-HCC3153, geldanamycin resulted in only a 2-to 3-fold in- with CYP3A4 (Egorin et al., 1998) , quinine metabolizing en-
